Search

everythinglearnresearchcommunity

for

Search:↓

Patients often experience long-lasting changes to their hair after stem cell transplants.

Most women with excess hair growth had Polycystic Ovary Syndrome, and severity wasn't linked to hormone levels.

The patient with Ankylosing Spondylitis had shoulder joint damage and bone changes.

Skin symptoms can indicate endocrine disorders and have various treatments.

In 2011, there were major scientific breakthroughs in cancer treatment, immunity, Parkinson's, virus simulation, schizophrenia, hair growth, lung cancer, and medical grafts.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Hair follicles may soon be used more for targeted and systemic drug delivery.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Reflectance confocal microscopy confirms that yellow dots are signs of damaged hair follicles in alopecia areata.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Lipedematous scalp is mainly caused by an increase in fat tissue under the skin and is different from lipedematous alopecia.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Oral steroids may effectively treat recurrent intussusception in children with ILH, possibly avoiding surgery.

New techniques for treating scalp blood vessel malformations are effective and can have good cosmetic results.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Lovastatin doesn't improve lower urinary tract symptoms treatment.